How pharma could feel the pain of a recession
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Fri.Mar 21, 2025
232 
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
MARCH 21, 2025
Todays guest post comes from Greg Skalicky, President of EVERSANA. Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). He introduces us to EVERSANA DIRECT Commercialization, a direct-to-patient change/model. To learn more about EVERSANA DIRECT Commercialization and how the direct-to-patient model can help you, meet with EVERSANA at the Asembia Summit in Las Vegas
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
The Guardian - Pharmaceutical Industry
MARCH 21, 2025
Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.
Delayed CDC meeting on vaccines is rescheduled to April
BioPharma Dive
MARCH 21, 2025
A panel of CDC advisers, who had been set to meet in February, will discuss the current measles outbreak as well as guidelines for several types of shots.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Alnylam joins three-way contest in ATTR cardiomyopathy
pharmaphorum
MARCH 21, 2025
Alnylam has claimed FDA approval for Amvuttra in ATTR cardiomyopathy, allowing it to compete with rival therapies from Pfizer and BridgeBio.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Fabhalta is first FDA-approved therapy for rare disease C3G
pharmaphorum
MARCH 21, 2025
Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target
J&J boosts US operations with $55bn investment
Pharmaceutical Technology
MARCH 21, 2025
J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.
Alnylam prices heart drug at premium to rivals
BioPharma Dive
MARCH 21, 2025
Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio. But executives argue its “compelling and highly differentiated value” justify the higher charge.
Menarini to enhance BPDCN detection with VisualDx’s link
Pharmaceutical Technology
MARCH 21, 2025
Menarini Group has announced a partnership with VisualDx to enhance the diagnosis of individuals with BPDCN.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
J&J boosts US manufacturing as big pharma reshores
BioPharma Dive
MARCH 21, 2025
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Pharmaceutical Technology
MARCH 21, 2025
J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.
Pharma is running out of names. Can an AI help?
pharmaphorum
MARCH 21, 2025
Pharma is running out of names. Can an AI help? Jonah.
Global funding cuts reversing decades of tuberculosis progress, WHO says
Pharmaceutical Technology
MARCH 21, 2025
Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the disease.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
AstraZeneca deepens China investment; Editas loses CFO to Dyne
BioPharma Dive
MARCH 21, 2025
The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.
Mastering compliance and copyright in healthcare and MedComms
Pharmaceutical Technology
MARCH 21, 2025
Understanding reuse rights and copyright compliance is critical, particularly in todays ever-evolving technological landscape.
AZ builds in China, as J&J ramps up its US investments
pharmaphorum
MARCH 21, 2025
AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
European agencies catch up with speedier regulatory pathways for CGTs in the US
Pharmaceutical Technology
MARCH 21, 2025
Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
EMA panel endorses AI for MASH clinical trials
pharmaphorum
MARCH 21, 2025
PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.
APhA 2025: Pharmacists Can Prescribe Contraceptives in 30 States and the District of Columbia
Pharmacy Times
MARCH 21, 2025
Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.
J&J adds to IL-23 options in Crohn's after FDA approval
pharmaphorum
MARCH 21, 2025
J&J's Tremfya gets a much-anticipated FDA approval for Crohn's disease, which the company thinks will be key to a renewed phase of sales growth.
BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement
Pharmacy Times
MARCH 21, 2025
Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care
Pharmacy Times
MARCH 21, 2025
This subset of heart failure requires unique therapeutic considerations.
Academic medical centers say funding cuts jeopardize health research
BioPharma Dive
MARCH 21, 2025
Proposed cuts to National Institutes of Health funding threaten innovation necessary to fuel advances in patient care, researchers and provider groups say.
Navigating FIP: Strategies for Diagnosis & Treatment
epicur
MARCH 21, 2025
Get up-to-date treatment protocols and practical guidance that will help you confidently manage FIP cases in your practice.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Let's personalize your content